Clinical Assessment of a Supplement of Pycnogenol® and l‐arginine in Japanese Patients with Mild to Moderate Erectile Dysfunction
Citations Over TimeTop 19% of 2011 papers
Abstract
A double-blind parallel group comparison design clinical study was conducted in Japanese patients with mild to moderate erectile dysfunction to investigate the efficacy of a supplement containing Pycnogenol® and L-arginine. Subjects were instructed to take a supplement (Pycnogenol® 60 mg/day, L-arginine 690 mg/day and aspartic acid 552 mg/day) or an identical placebo for 8 weeks, and the results were assessed using the five-item erectile domain (IIEF-5) of the International Index of Erectile Function. Additionally, blood biochemistry, urinalysis and salivary testosterone were measured. Eight weeks of supplement intake improved the total score of the IIEF-5. In particular, a marked improvement was observed in 'hardness of erection' and 'satisfaction with sexual intercourse'. A decrease in blood pressure, aspartate transaminase and γ-glutamyl transpeptidase (γ-GTP), and a slight increase in salivary testosterone were observed in the supplement group. No adverse reactions were observed during the study period. In conclusion, Pycnogenol® in combination with L-arginine as a dietary supplement is effective and safe in Japanese patients with mild to moderate erectile dysfunction.
Related Papers
- → The herbal composition Green Love® improves erectile function in patients with erectile dysfunction: A pilot study to evaluate effectiveness and safety(2017)1 cited
- → The effect of antihypertensive treatment on erectile function(2005)
- Age-related erectile function differences among erectile dysfunction patients(2014)
- → Faculty Opinions recommendation of Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial.(2011)